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ABSTRACT: The monoterpene thymol has been proposed as a valuable
alternative to in-feed antibiotics in animal production. However, the eﬀectiveness
of the antimicrobial is comprised by its fast absorption in the upper gastrointestinal
tract. In this work, two glucoconjugates, thymol α-D-glucopyranoside (TαG) and
thymol β-D-glucopyranoside (TβG), were compared with free thymol for their
potential to deliver higher concentrations of the active compound to the distal
small intestine of supplemented piglets. Additionally, an analytical method was
developed and validated for the simultaneous quantiﬁcation of thymol and its
glucoconjugates in diﬀerent matrices. In stomach contents of pigs fed with 3333
μmol kg−1 thymol, TαG, or TβG, total thymol concentrations amounted to 3048,
2357, and 1820 μmol kg−1 dry matter, respectively. In glucoconjugate-fed pigs,
over 30% of this concentration was present in the unconjugated form, suggesting
partial hydrolysis in the stomach. No quantiﬁable levels of thymol or
glucoconjugates were detected in the small intestine or cecum for any treatment,
indicating that conjugation with one glucose unit did not suﬃciently protect thymol from early absorption.
■ INTRODUCTION
Thymol (2-isopropyl-5-methylphenol, Figure 1) is the main
monoterpene component of the essential oil derived from
Thymus species. The phenolic compound exhibits strong
antimicrobial and antioxidant properties.1 Therefore, it has
been used in human medicine and the food industry for
centuries.2 More recently, phytochemicals received increasing
interest for their application in animal nutrition due to the
need for a reduction in the use of antibiotics. Thymol has been
suggested as a valuable alternative for these in-feed antibiotics,
especially for weaned piglets as weaning is a stressful event
often associated with dysbiosis of gut microbiota and
proliferation of pathogens, such as enterotoxigenic Escherichia
coli, particularly in the distal small intestine.3 Although the
bactericidal capacity of thymol has been extensively demon-
strated in vitro,1,4−6 its application in animal feeds has several
limitations. Next to its volatility and pungent taste at high
concentrations, the main restriction is the fast and complete
absorption of thymol in the upper gastrointestinal tract (GIT),
resulting in insigniﬁcant concentrations at the level of the
lower GIT, which are insuﬃcient for the desired antibacterial
eﬀects.7,8 Hence, protection of the molecule is opportune to
obtain eﬀective luminal concentrations in the distal section of
the small intestine.
Encapsulation is a popular measure to increase the stability
and functional performance of essential oils. A wide array of
matrices (e.g., whey proteins, triglycerides, and maltodextrins)
and techniques (e.g., spray drying and extrusion) are available,
each with their advantages and drawbacks.9,10 However, the
existing encapsulations of essential oils are primarily designed
for food and pharmaceutical applications.9 Many of the
encapsulated feed additives are still in the laboratory stage,10
and only few formulations have been validated in pigs, with
variable success in enhancing intestinal release.11−13 Moreover,
application of this approach for animal nutrition is limited by
cost considerations.14
Glycosylation is an alternative protective method that has
been used for various pharmaceuticals in the past, thus creating
prodrugs.15 It also reduces the volatility of the aglycon16 and
masks the pungent taste of thymol,17 which is advantageous for
application in animal feeds. Enzymatic glycosylation uses cheap
resources (e.g., sucrose) and oﬀers the possibility to synthesize
an array of glycoconjugates with various sugar moieties in the
form of mono-, di-, or polyglycosides18 Moreover, a large
variety of plant secondary metabolites naturally occur as
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glycosides, increasing their water solubility and altering their
biological activity.19 The functionality of these glycoside
prodrugs depends on the release of the active aglycon at the
target site by cleavage of the glycosidic bond by glycoside-
hydrolyzing enzymes. These glycosidases are present in the
GIT of mammals and are either of endogenous or bacterial
origin.15
To date, only one glycoside of thymol, namely, thymol β-D-
glucopyranoside (TβG), has been investigated as a protected
form of thymol in animal nutrition. Petrujkic et al.20 compared
the absorption of thymol and TβG in everted jejunal segments
of the pig and concluded that the glucoconjugate was 2.3 and
2.8 times more resistant to absorption than pure thymol from 1
and 3 mmol L−1 solutions, respectively. Furthermore, oral
administration of TβG resulted in signiﬁcant reduction of the
Campylobacter level in the crop of market-aged broilers,
whereas pure thymol did not, as compared to a negative
control.21 However, TβG has not been evaluated in vivo as a
feed additive in pigs.
This work focuses on thymol α-D-glucopyranoside (TαG),
the anomer of TβG (Figure 1), which has, to the best of our
knowledge, not yet been investigated for its potential to deliver
thymol to the distal small intestine. It is hereby assumed that
there is suﬃcient glycosidase activity present for gradual
release of the active aglycon thymol along the GIT. First, an
analytical method was developed and validated for the
simultaneous quantiﬁcation of thymol and TαG in diﬀerent
matrices. Thereafter, an in vivo feeding trial was conducted to
test and compare the retention of TαG along the GIT of
piglets with that of free thymol and its anomer TβG.
■ RESULTS
Method Validation for the Analysis of Thymol and
TαG. Selectivity. The method is considered selective as no
interfering peaks originating from the matrix could be
identiﬁed at the retention times of the peaks of interest,
being 10.2, 17.2, 22.0, and 23.9 min for pNPG, TαG, iPP, and
thymol, respectively.
Linearity. The calibration curves, expressed as the ratio of
the peak areas of the analyte and its respective internal
standard versus concentration, were found to be linear for both
thymol and TαG over the concentration range of 5−1200 mg
kg−1 for all matrices tested. Regression equations and
determination coeﬃcients (R2) are displayed in Table 1.
Accuracy, Precision, and Recovery. The values for the
validation parameters accuracy, precision, and recovery are
listed in Table 2. The method can be considered accurate and
precise. The accuracy ranged from 84.7 to 107.6% and 87.6 to
108.2% for thymol and TαG, respectively, at three
concentrations in four diﬀerent matrices. Recoveries were in
the range of 95 to 118% for thymol and 95 to 122% for TαG.
The highest values were found in feed at a dose of 100 mg
kg−1, indicating possible overestimation of the analyte
concentrations in feed. This should, however, not pose a
problem in the current study as concentrations added to the
feed of the in vivo trial were 5 to 10 times higher.
Sensitivity. The LOD and LOQ are key parameters in
method validation as they determine the lowest concentration
of the analyte, which can be reliably distinguished from the
baseline or quantitated, respectively. The values for LOD and
LOQ are presented in Table 1.
Based on the obtained validation parameters presented
above, the method is considered satisfactory for its application
on in vivo samples.
Concentrations of Thymol and Its Glucosides in the
GIT In Vivo. To study the retention of thymol and its two
glucosides in the lumen of the GIT of pigs, animals were fed
with these compounds for 1 day in discrete meals every 2 h. All
piglets consumed the total amount of feed oﬀered on the day
of sampling. The additive concentrations in the feed
(expressed on fresh matter basis) were analytically checked
and found to diﬀer slightly from the intended dose (3333 μmol
Figure 1. Chemical structures of (a) thymol, (b) thymol β-D-glucopyranoside, and (c) thymol α-D-glucopyranoside
Table 1. Parameters of Calibration Curves, Limit of Detection (LOD), and Limit of Quantiﬁcation (LOQ) of Thymol and
Thymol α-D-Glucopyranoside in Diﬀerent Matrices
matrix regression equation R2 LOD (mg kg−1) LOQ (mg kg−1)
thymol
feed y = 0.0086x − 0.0538 0.9962 3.5 10.6
gastric digesta y = 0.0106x − 0.0877 0.9906 5.8 17.6
small intestinal digesta y = 0.0102x − 0.0007 0.9943 6.4 19.5
cecal digesta y = 0.0094x − 0.0064 0.9968 3.9 11.9
thymol α-D-glucopyranoside
feed y = 0.0035x + 0.0203 0.9982 5.7 17.3
gastric digesta y = 0.0045x + 0.0441 0.9962 8.6 26.1
small intestinal digesta y = 0.0040x + 0.0058 0.9991 5.5 16.6
cecal digesta y = 0.0040x + 0.0265 0.9979 7.7 23.3
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kg−1). The detected values were 3603 μmol thymol kg−1 for
CON, 2790 μmol TαG kg−1 plus 149 μmol free thymol kg−1
for αGLUC, and 3369 μmol TβG kg−1 for βGLUC. This
corresponds to a total thymol dose of 108, 88, and 101 μmol
kg BW−1 for the respective treatments. Further calculations
were based on the analytically veriﬁed concentrations in the
feed and expressed on DM basis to be able to compare across
compartments.
The detected concentrations of thymol, TαG, and TβG in
gastric contents of piglets 1 to 2 h post prandial condition are
presented in Table 3. Piglets orally supplemented with pure
thymol (CON) retained concentration levels in their stomach
that were, on average, 75.3% of the concentration present in
the feed (p < 0.001; Figure 2). When piglets were fed with the
monoglucosides TαG or TβG, the total thymol concentrations
(sum of free and glucoconjugated thymol) in stomach contents
were respectively 71.4% (p < 0.001) and 48.1% (p = 0.001) of
the original feed levels. Additionally, the total thymol
concentration at the level of the stomach was signiﬁcantly
lower in βGLUC (1820 μmol kg−1 DM) as compared to CON
piglets (3048 μmol kg−1 DM; p = 0.002), with αGLUC piglets
showing intermediate levels (2357 μmol kg−1 DM). The
proportion of the intact glucosides in the total thymol
concentrations were 66 and 63% for the αGLUC or βGLUC
treatment, respectively, while the remaining part was present as
free thymol. This ﬁnding implicates that the glucosides are
partially hydrolyzed in the stomach before absorption.
Additionally, there was a trend (p = 0.069) for lower intact
glucoside concentrations in the stomach of βGLUC pigs (1149
μmol kg−1 DM) compared to αGLUC pigs (1556 μmol kg−1
DM).
Only trace amounts (<LOQ) of free thymol were found in
small intestinal and cecum contents of pigs of either treatment.
Furthermore, no detectable levels of the glucosides were found
further in the GIT of the αGLUC or βGLUC piglets.
■ DISCUSSION
To evaluate the retention of thymol and TαG from the GIT of
piglets, it was essential to develop a reliable method to extract
these compounds from and quantify them in feed and digesta
of diﬀerent gastrointestinal sites. With one exception,22 most
Table 2. Accuracy (%), Precision (RSD%), and Recovery
(%) of Thymol and Thymol α-D-Glucopyranoside in
Diﬀerent Matrices
spiked concentration (mg kg−1)
thymol
thymol α-D-
glucopyranoside
matrix 50 100 500 50 100 500
feed
accuracy (n = 9) 91.5 90.6 84.7 87.6 98.0 95.2
intraday precision
(n = 3)
4.1 2.8 7.5 4.6 3.2 3.9
interday precision
(n = 3)
12.7 4.0 13.1 9.8 8.2 6.9
recovery (n = 3) 101.3 118.0 113.1 105.3 122.3 115.2
gastric digesta
accuracy (n = 9) 103.2 96.0 92.2 108.2 106.3 98.6
intraday precision
(n = 3)
4.9 5.7 5.2 6.5 5.3 2.7
interday precision
(n = 3)
6.1 8.4 5.4 9.1 7.5 3.4
recovery (n = 3) 103.2 114.6 95.3 106.3 116.4 98.2
small intestinal
digesta
accuracy (n = 9) 102.3 94.7 95.5 99.1 98.2 96.1
intraday precision
(n = 3)
11.9 6.7 8.4 1.4 1.4 2.2
interday precision
(n = 3)
13.4 7.5 10.5 3.4 2.3 2.6
recovery (n = 3) 110.6 103.9 105.7 96.5 96.1 100.1
cecal digesta
accuracy (n = 9) 109.3 105.9 107.6 99.9 100.4 99.7
intraday precision
(n = 3)
5.1 5.9 11.5 6.1 4.3 0.5
interday precision
(n = 3)
10.4 6.3 15.4 6.1 4.9 0.9
recovery (n = 3) 104.4 112.0 98.6 101.0 96.7 94.8
Table 3. Analyte Concentrations in Feed and the Stomach
Contents of Piglets of Diﬀerent Treatments (μmol kg−1 Dry
Matter)
analyte feed stomacha p-valueb
CONc
free thymol 4049 3048 ± 132 <0.001
TαGc NDd ND
TβGc ND ND
total thymol 4049 3048 ± 132 <0.001
αGLUCc
free thymol 167 801 ± 109 0.001
TαGc 3135 1556 ± 133 <0.001
TβGc ND ND
total thymol 3302 2357 ± 136 <0.001
βGLUCc
free thymol ND 672 ± 156
TαGc ND ND
TβGc 3786 1149 ± 150 <0.001
total thymol 3786 1820 ± 283 0.001
aExpressed as mean ± SE. bGenerated via a one-sample t-test (n = 6)
with feed concentration as the test value. cAbbreviations: CON,
control treatment with an intended dose of 3333 μmol of thymol per
kg of feed; αGLUC, treatment with an intended dose of 3333 μmol of
thymol α-D-glucopyranoside per kg of feed; βGLUC, treatment with
an intended dose of 3333 μmol of thymol β-D-glucopyranoside per kg
of feed; TαG, thymol α-D-glucopyranoside; TβG, thymol β-D-
glucopyranoside. dND, not detected; value below limit of detection.
Figure 2. Concentrations of analytes in feed (striped bars) and
stomach contents (full bars) of piglets fed with thymol (CON),
thymol α-D-glucopyranoside (αGLUC), or thymol β-D-glycopyrano-
side (βGLUC). Error bars indicate the SEM (n = 6) in stomach
contents. Percentages reﬂect diﬀerences in total thymol concen-
trations (sum of free and glucoconjugated thymol). Asterisks (*)
indicate signiﬁcant diﬀerences, which were tested via a one-sample t-
test with the corresponding feed concentration as the test value.
Diﬀerent letters (a, b) indicate a signiﬁcant diﬀerence in total thymol
concentration of stomach contents between treatments tested with a
one-way ANOVA procedure (p = 0.002).
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published methods for the analysis of thymol conjugates7,20,23
involve a ﬁrst step of enzymatic hydrolysis. The amount of
conjugates is then indirectly calculated from the diﬀerence in
thymol concentration before and after hydrolysis. The accuracy
of indirect methods is highly dependent on the selectivity and
progression of the enzymatic reactions.24 The method
proposed in this study avoids indirect hydrolysis and proved
to fulﬁll all set requirements for validation. The sensitivity was
judged to be suﬃciently high for quantiﬁcation of the analytes
in digesta of this particular in vivo trial. If no absorption would
occur, then the dietary levels are diluted 4 times in gastric
contents (mean DM content of 25%) and 10 times in small
intestinal contents (mean DM content of 10%). Taking into
account the administered doses of thymol (500 mg kg−1) and
TαG (1040 mg kg−1), the expected maximal concentrations
amount approximately 125 and 260 mg kg−1 in stomach and
50 and 104 mg kg−1 in small intestine for thymol and TαG,
respectively. These values are all above the LOQ. However, it
should be mentioned that, when applying lower doses, the
sensitivity of this method might be insuﬃcient. In this case, the
remaining concentrations in the GIT are also below the range
of minimum inhibitory concentrations against several
pathogens1 and thus functionally not relevant for our purpose.
The major drawback for the use of thymol as an
antimicrobial compound in live animals is its fast clearance
from the upper GIT. Therefore, the luminal concentrations in
the distal small intestine remain below the bactericidal
thresholds.7,8 The lower thymol concentrations retrieved
from the stomach contents of thymol-fed piglets as compared
to the feed and the absence of quantiﬁable amounts in digesta
from the small intestine in this study conﬁrm these ﬁndings.
Glucoconjugation of the monoterpene has been tested here as
a way to deliver higher concentration to the lower gut region.
Glucosides are more hydrophilic and have a larger molecular
size, which makes them more resistant to penetration of
epithelial membranes.25 Moreover, the pungent taste of the
aglycon is masked and its volatility reduced by this
glucoconjugation. However, it was shown by Epps et al.26
and Levent et al.27 that TβG has no antimicrobial activity and
that its ability to reduce bacterial populations depends on the
presence of glucoside-hydrolyzing enzymes to release the
active aglycon. The abundance of glucosidase enzymes in the
proximal GIT is thought to be rather low. On the contrary, the
high level of glucosidase activity in the distal GIT should
release the active aglycon at the target sites.15,28 In the current
study, however, the total thymol concentration remaining in
the stomach of piglets fed with TαG or TβG was signiﬁcantly
lower than that in the feed, indicating that some absorption
already took place under the assumption that thymol as such is
not broken down by microbiota in the foregut.7 Moreover,
feeding TβG resulted in total thymol concentrations in the
stomach that were 40% lower than in the thymol treatment.
Supplementing TαG gave intermediate total stomach concen-
trations. Hence, feeding glucoconjugates of thymol did not
result in higher luminal thymol concentrations in the stomach
as compared to supplementation of free thymol. On the
contrary, the β-glucoside form seemed to disappear faster from
the chyme than its aglycon. This is in agreement with the study
of Cermak et al.,29 who administered an equimolar dose of
quercetin or its β-glucoside isoquercitrin to pigs and registered
a 50% increase in bioavailability from the glucoside as
compared to the aglycon. Moreover, for both quercetin and
isoquercitrin, the main metabolite appeared in the blood
circulation within 1 h after administration, but the peak of the
latter was higher. This indicated that isoquercitrin was
absorbed faster, but still from the same site, namely, the
upper GIT.29 Actually, intact absorption at the level of the
stomach has been suggested for some glucoconjugated
anthocyanidins without prior hydrolysis,30,31 although this
was not the case for the ﬂavonoid glucosides of quercetin32 and
daidzein.33 Therefore, it remains to be elucidated whether
absorption of glucoconjugated thymol through the gastric wall
contributes to the reduced total thymol concentration as
compared to aglycon supplementation. In any case, the
observed thymol glucoconjugate clearance from the upper GI
tract does not favor the antimicrobial action in the hindgut, yet
it might promote the systemic antioxidant34 or anti-
inﬂammatory activity.35
In the stomach contents of αGLUC and βGLUC piglets,
more than 30% of the total thymol was present in the free
form, suggesting that hydrolysis of both TαG and TβG took
place in the stomach. Additionally, the intact TαG
concentration in stomach tended to be higher as compared
to TβG (p < 0.10), despite the slightly lower TαG
concentration in feed. This implies that the α-bound
conjugates might be more resistant to hydrolysis and
absorption than the β-bound ones. Early glucoside hydrolysis
was also suggested by Epps et al.,21 who found reduced counts
of Campylobacter in the crop of broilers fed with TβG. As
mentioned before, intact TβG has no antimicrobial activity, so
hydrolysis and release of the biologically active aglycon must
have occurred in the crop. By contrast, Crespy et al.32
measured virtually unaltered concentrations of isoquercitrin in
the rat stomach 30 min after gastric administration, while 38%
of the administered aglycon, quercetin, was absorbed. The
authors concluded that the stomach does not play a crucial role
in absorption nor hydrolysis of glucosides. Important diﬀer-
ences of this rat study with our study might be the absence of
feed in the stomach and the lack of contact between the
compounds and saliva as the compounds were administered
intragastrically. Indeed, Walle et al.36 demonstrated the
hydrolysis of quercetin, phloretin, and genistein glucosides
by human saliva. It is rather implausible that these monogluco-
sides were hydrolyzed by salivary α-amylases as these enzymes
are endosaccharidases that have no eﬀect on terminal glucose
molecules,37 although the required glucosidase activity most
likely originated from bacteria and shed epithelial cells present
in the oral cavity.36 Otherwise, gastric bacteria might also
contribute to glucoside hydrolysis. Unlike humans, piglets
harbor relatively large numbers of bacteria in their stomach,
among which are Lactobacilli and Enterococci, who are known
to exhibit glucosidase activities.38−40 Hydrolysis due to the low
pH in the stomach does not probably add to the appearance of
the aglycon as the temperature requirements for signiﬁcant
acid hydrolysis are much higher than physiological temper-
atures.41,42 Deconjugation of the glucosides in the feed, prior
to ingestion, might also be suggested as the presence of
glucosidase activity has been shown in many plants commonly
used as feed ingredients such as maize, soybean, and wheat.43
The occurrence of free thymol in the current study is not likely
attributable to in-feed hydrolysis because the compounds were
mixed in the feed only 1 day prior to feeding. The minor
fraction of free thymol that was present in the αGLUC feed
originates from an impurity of the TαG product. Hence, the
occurrence of free aglycon levels in the stomach contents is
thought to originate mainly from bacterial activity in both
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saliva and stomach, although further research is warranted to
conﬁrm this hypothesis and to elucidate why the β-glucoside
tends to be more easily hydrolyzed than its α-isomer.
As expected, free thymol levels in the small intestine and
cecum were very low, even below the quantiﬁcation limit,
irrespective of the treatment. This is largely in accordance with
the ﬁndings of Michiels et al.,7 although they still retrieved a
minor fraction of the ingested essential oils in SI1. This
diﬀerence might be explained by the way of administration: a
single dose versus spread in meals in our study and by the
application of another extraction and analysis method.
Surprising was the inability to detect any glucosides in digesta
of αGLUC and βGLUC piglets as of SI1 in our study. Similar
results were obtained by feeding black raspberry powder,
containing cyanidin-3-glucoside among other glycosides to
weaner pigs. Four hours after the meal, the monoglucoside
almost completely disappeared from small intestinal contents,
and only 2% of the total intake was recovered in cecum and
colon.44 We assume that the amount of monoglucosides
remaining in the chyme must be absorbed almost instanta-
neously in the duodenum upon gastric emptying, as is the case
for thymol. Although, to date, no studies are available that deal
with the absorption route of thymol glucosides, much research
has been done on quercetin glucosides. With regard to the
absorption of monoglucosides across the intestinal membrane,
two hypotheses exist. First, glucosides might be hydrolyzed by
small intestinal glucosidases, such as the membrane-bound
lactase phlorizin hydrolase, before trans-epithelial absorption of
the aglycon by passive diﬀusion occurs.45,46 Second, there
might be carrier-mediated uptake of the monoglucoside as
such by the sodium-dependent glucose transporter-1.47
Moreover, the bioavailability and the rate of small intestinal
absorption of quercetin were demonstrated to be highly
dependent on the glycoside moiety to which it is conjugated.
Indeed, glucose conjugates were rapidly absorbed, while other
glycosides, such as galactose, rhamnose, and glucorhamnose,
were more resistant to intestinal hydrolysis and absorption.29,48
Hence, it could be of interest to synthesize and investigate the
potential of thymol conjugates with glycons other than glucose
or with more than one sugar unit to obtain delayed absorption
of the aglycon.
In conclusion, we observed that glucoconjugation did not
protect thymol from early absorption in the proximal GIT of
piglets. Supplementation of TβG even seemed to increase the
absorption rate in the stomach as compared to the aglycon, as
appeared from the 40% lower total thymol concentrations in
the chyme. Importantly, it was shown that both thymol
glucosides are subject to partial hydrolysis in the stomach, yet
TαG seemed more resistant than TβG. Although the
contribution of bacteria from the oral cavity and stomach is
plausible, the mechanisms of glucoside hydrolysis in the
stomach need further investigation.
■ MATERIALS AND METHODS
Chemicals. Thymol (99.5% purity) was obtained from
Sigma-Aldrich (Bornem, Belgium). Thymol α-D-glucopyrano-
side (97% purity, 0.8% free thymol) was enzymatically
synthesized according to the procedure described by De
Winter et al.18 from a reaction mixture containing thymol (5 g
L−1) and sucrose (1 mol L−1) and facilitated by the R134A
mutant of Thermoanaerobacterium thermosaccharolyticum su-
crose phosphorylase (4 U mL−1). Thymol β-D-glucopyranoside
(99.4% purity) was purchased from Glentham Life Sciences
Ltd. (Corsham, U.K.). The internal standards 2-isopropylphe-
nol (≥98% purity) and 4-nitrophenyl α-D-glucopyranoside
(99.8% purity) were purchased from Fluka (Bornem, Belgium)
and Carbosynth Ltd. (Berkshire, U.K.), respectively. All
organic solvents were of HPLC grade and water was of
Milli-Q quality (Merck Millipore, Darmstadt, Germany).
Standard Solutions and Calibration Curves. Thymol
and TαG were accurately weighed in the same tube and
subsequently dissolved in ethanol to obtain a stock solution
containing 24 g L−1 of both analytes. The standard solutions
were made by further diluting the stock solution with the
appropriate amounts of ethanol. A separate calibration curve
was constructed for following matrices: feed and digesta from
stomach, small intestine, and cecum. The calibration curves
were obtained by adding the standard solutions to blank
samples, resulting in ﬁnal thymol and TαG concentrations of 5,
25, 50, 100, 250, 500, 1000, and 1200 mg kg−1. The blank
samples from gastric, small intestinal, and cecal digesta for
matrix-matched calibration curves and the assessment of
validation parameters were pooled samples obtained from
pigs fed with a diet free from any thymol compounds. Two
internal standard solutions were prepared: 2-isopropylphenol
(iPP; 25 g L−1) for thymol7 and 4-nitrophenyl α-D-
glucopyranoside (pNPG; 0.5 g L−1) for TαG.
Sample Preparation. All samples were extracted and
analyzed in triplicate, unless stated otherwise. Samples were
acidiﬁed to pH < 2 with 2% 6 mol L−1 H2SO4 solution to
prevent fermentation before adding the test compounds
(validation procedure) or at sample collection (in vivo trial).
The liquid−liquid extraction procedure was adapted from
Gallo et al.49 One gram of sample was weighed in a 15 mL
glass vial with a screw cap with septum. Next, each sample was
spiked with 50 μL of iPP and pNPG internal standards.
Thereafter, 2 mL of the extraction solvent consisting of ethyl
acetate, 1-butanol, and 1-propanol (60:30:10, v/v/v) was
added. The samples were ﬁrst vigorously mixed on a vortex
apparatus for 30 s and then shaken horizontally on an orbital
shaker (300 rpm) for 1 h, followed by centrifugation (2000g,
10 min) and transfer of the organic top layer. The extraction
procedure was repeated a second time following 30 min
shaking. Subsequently, the organic phase was evaporated to
dryness under nitrogen gas at 40 °C. The dry residue was
reconstituted in 1 mL of a mixture of water and acetonitrile
(65:35, v/v) and ﬁltered with a cellulose syringe ﬁlter (0.2
μm). Aliquots of 20 μL were injected in the HPLC system
upon analysis.
Chromatographic Condition. Liquid chromatography
was performed on an Agilent Technologies 1200 series LC
system. Chromatographic separation was acquired on a
reversed-phase C18 column (Supelcosil LC-18, 5 μm, 25 cm
× 4.6 mm i.d.) maintained at 35 °C and protected by a
Supelguard cartridge (Supelcosil LC-18, 5 μm, 2 cm × 4 mm
i.d.). Mobile phases consisted of water (solvent A) and
acetonitrile (solvent B), both with 1 mL L−1 formic acid. The
elution gradient was set as follows [time in minutes (% B)]: 0
(5), 5 (5), 25 (60), and 30 (100), with a ﬂow rate of 2 mL
min−1. Thymol, TαG, and TβG were detected at the
wavelength of 280 nm.
Method Validation. The method was validated according
to the International Conference of Harmonization (ICH)
Guideline for the Validation of Analytical Procedures. For each
biological matrix (feed, gastric, small intestinal, and cecal
contents), the following validation parameters were evaluated:
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selectivity, linearity, precision and accuracy, recovery, limit of
detection (LOD), and limit of quantiﬁcation (LOQ). Because
of budget constraints, the method was only validated for
thymol and TαG, not for TβG.
Selectivity. Selectivity was evaluated by comparing
chromatograms of nine blank samples of each matrix with
corresponding spiked samples and testing for peak interfer-
ences.
Linearity. For the linearity study, blank samples were spiked
simultaneously with thymol and TαG, as described in the
previous section (standard solution and calibration curves).
The calibration curves consisted of blank samples and eight
concentration levels ranging from 5 to 1200 mg kg−1 of both
analytes. This range was chosen based on the expected
concentrations in the samples of the current in vivo experiment.
The dependent variable in the linear regression analysis was
calculated as the ratio of peak area of the analyte/peak area of
its respective internal standard. Linearity was evaluated using
linear regression analysis calculated with the least-squares
method.
Accuracy, Precision, and Recovery. Accuracy, within- and
between-day precision, and recovery were determined by
analyzing spiked samples at three diﬀerent concentrations: low
(50 mg kg−1), medium (100 mg kg−1), and high (500 mg
kg−1). The analysis was performed in triplicate and on three
consecutive days by the same analyst (interday precision) for
every matrix. Accuracy was calculated as the ratio between the
mean measured concentration and the nominal concentration
multiplied by 100, while precision was expressed as the relative
standard deviation (RSD) of the measured concentrations.
Concentrations were calculated from the obtained peak areas
using the previously mentioned calibration curves. Recovery
was determined by comparing the response of the samples
spiked before extraction with the response from blank samples
that were spiked after extraction and drying. The response is
deﬁned as the ratio between the peak areas of the analyte and
the respective internal standard.
Sensitivity. Sensitivity is determined by the LOD and LOQ.
For this purpose, a separate eight-point calibration curve was
constructed in the lower concentration regions (1−25 mg
kg−1) for each matrix. LOD and LOQ were calculated as the
ratio of the RSD of the regression line and the slope of the
calibration curve multiplied by 3.3 and 10, respectively.
In Vivo Absorption of Thymol and Its Glucosides.
Animal Housing and Treatments. The study was conducted
in accordance with the ethical standards and recommendations
for accommodation and care of laboratory animals covered by
the European Directive 2010/63/EU on the protection of
animals used for scientiﬁc purposes and the Belgian royal
decree KB29.05.13 on the use of animals for experimental
studies.
Eighteen female piglets (Topigs × Piet́rain) with a mean
body weight (BW) of 24.0 ± 0.6 kg were selected from a herd
and housed per two in a pen with full slated ﬂoors. The stable
had a conventional ventilation scheme, ambient temperature at
24 °C, and a 18 light/6 dark schedule. The animals were
allocated to treatments (n = 6) with stratiﬁcation for BW.
Subsequently, the pens were assigned to the treatments
according to a randomized block design. Piglets were adapted
to meal feeding for 7 days during which they received an
appropriate basal diet for growing piglets (Table 4), provided
in eight equal meals per day between 6 a.m. and 8 p.m. This
approach was used to mimic steady-state conditions in the
GIT. The total daily feed intake was restricted to 40 g kg−1 BW
(equivalent to approximately 90% of the ad libitum feed
intake). Animals were allowed to eat for 30 min per meal, after
which the residual feed was collected and weighed. From day 6
onward, all animals consumed the total amount of feed
provided. Water was available ad libitum during the whole
experiment. On the day of sampling (day 8), animals received
six meals of their respective experimental diets with a 2 h
interval and were ﬁnally euthanized between 1 and 2 h after
their last meal. Experimental diets consisted of the basal diet
supplemented with 3333 μmol kg−1 thymol (equivalent to 500
mg kg−1; CON treatment), an equimolar amount of thymol-α-
D-glucopyranoside (1040 mg kg−1; αGLUC treatment), or
thymol-β-D-glucopyranoside (1040 mg kg−1; βGLUC treat-
ment).
Sample Collection and Analysis. Animals were ﬁrst
brought to electronarcosis followed by exsanguination. The
entire GIT was removed, exposed, and partitioned in ﬁve
digesta sampling sites: stomach, three parts of the small
Table 4. Ingredient and Analyzed Nutrient Composition of
the Basal Diet (g kg−1 as Feed)
ingredient composition
wheat 355.00
barley 300.00
soybean meal 136.22
corn 80.00
toasted soybeans 40.00
sugarbeet pulp 20.00
animal fat 19.94
premix minerals and vitaminsa 5.00
soybean oil 10.00
L-lysine 9.25
dicalciumphosphate 8.02
limestone 6.96
L-threonine 2.28
salt 2.00
sodium bicarbonate 1.95
DL-methionine 1.62
L-valine 1.17
L-tryptophan 0.61
analyzed nutrient composition
dry matter 892.9
crude ash 47.3
crude protein 182.0
ether extract 54.5
crude ﬁber 36.0
aProviding per kg of diet: vitamin A (retinyl acetate), 15,000 IU;
vitamin D3 (cholecalciferol), 2000 IU; vitamin E (all-rac-α-
tocopherylacetate), 50.0 mg; vitamin K3 (menadion), 4.0 mg; vitamin
B1 (thiamine mononitrate), 3.1 mg; vitamin B2 (riboﬂavin), 8.0 mg;
vitamin B3 (calcium-D-pantothenate), 20 mg; vitamin B6 (pyridoxine
hydrochloride), 6.0 mg; vitamin B12 (cyanocobalamin), 50.0 μg;
vitamin PP (niacinamide), 40.0 mg; folic acid, 2.0 mg; biotin, 0.3 mg;
betaine anhydrate, 285 mg; endo-1,4-β-glucanase E3.2.1.4, 250 TGU;
endo-1,4-β-xylanase E3.2.1.8, 560 TXU; 6-phytase, 500 OTU; Fe
(iron(II)sulfate monohydrate), 24.0 mg; Cu (copper(II)sulfate
pentahydrate), 155.0 mg; Zn (Zn MHA), 100.0 mg; Mn (manganese-
(II)oxide), 48.0 mg; I (calcium iodate anhydrate), 1.9 mg; Se (sodium
selenite), 200 μg; Se (selenomethionine produced by Saccharomyces
cerevisiae NCYC-R397), 100 μg; E306 extract of vegetable oils rich in
tocopherols, 228 mg; clinoptioliet, 1.64 g; aromatic compounds, 72
mg.
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intestine (SI1, SI2, and SI3 corresponding to segments of 0−
25%, 25−75%, and 75−100% of the total length, respectively),
and cecum. The contents of each compartment were
quantitatively collected. An aliquot of the fresh digesta was
acidiﬁed to pH < 2 with 2% 6 mol L−1 H2SO4 and stored at
−20 °C. These samples were further processed as described
earlier for determination of the concentration of thymol and its
glucosides. The remaining intestinal contents were frozen and
freeze-dried to determine dry matter (DM) contents. Feed
samples were collected to verify the concentrations of the
analytes.
Statistical Analysis. Data analysis was performed with
SPSS Statistics 24.0 program (SPSS Inc., Chicago, USA).
Assumptions of normality and equality of variances were
checked using the Shapiro−Wilkinson and Levene tests,
respectively. Results were analyzed using t-tests and ANOVA
procedures on the 5% signiﬁcance level.
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glucopyranoside; TβG, thymol β-D-glucopyranoside
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